山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (9): 55-60.doi: 10.6040/j.issn.1671-7554.0.2024.0271
• 主动脉疾病基础与临床研究进展专刊—研究进展 • 上一篇 下一篇
范立彬1,2,张鸿坤1
FAN Libin1,2, ZHANG Hongkun1
摘要: 腹主动脉瘤是严重的血管外科疾病,可危及生命,其发病率逐年上升。腹主动脉瘤腔内修复术(endovascular aneurysm repair, EVAR)是目前肾下型腹主动脉瘤(abdominal aortic aneurysm, AAA)最广泛使用的治疗方法。Ⅱ型内漏是EVAR术后最常见的并发症,也是术后二次干预的主要原因,然而目前对Ⅱ型内漏的自然转归及治疗尚存在争议。本文拟通过对Ⅱ型内漏预防及治疗的研究进展进行文献回顾,为临床决策提供参考。
中图分类号:
| [1] Summers KL, Kerut EK, Sheahan CM, et al. Evaluating the prevalence of abdominal aortic aneurysms in the United States through a national screening database[J]. J Vasc Surg, 2021, 73(1): 61-68. [2] 王颖, 顾慧, 于鑫鑫, 等. 71例腹主动脉瘤的基线CT特征与病变进展的相关性[J]. 山东大学学报(医学版), 2022, 60(10): 62-67. WANG Ying, GU Hui, YU Xinxin, et al. Correlation between baseline CT features and progression of abdominal aortic aneurysm in 71 cases[J]. Journal of Shandong University(Health Sciences), 2022, 60(10): 62-67. [3] Cifuentes S, Mendes BC, Tabiei A, et al. Management of endoleaks after elective infrarenal aortic endovascular aneurysm repair: a review[J]. JAMA Surg, 2023, 158(9): 965-973. [4] Sun Y, Cai HB, Yang D, et al. Volumetric analysis of effectiveness of embolization for preventing type II endoleaks following endovascular aortic aneurysm repair[J]. J Vasc Surg, 2023, 77(3): 752-759. [5] 中华医学会外科学分会血管外科学组. 腹主动脉瘤诊断和治疗中国专家共识(2022版)[J]. 中国实用外科杂志, 2022, 42(4): 380-387. Chinese Society for Vascular Surgery, Chinese Society of Surgery, Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of abdominal aortic aneurysm(2022 edition)[J]. Chinese Journal of Practical Surgery, 2022, 42(4): 380-387. [6] Akmal MM, Pabittei DR, Prapassaro T, et al. A systematic review of the current status of interventions for type II endoleak after EVAR for abdominal aortic aneurysms[J]. Int J Surg, 2021, 95: 106138. doi:10.1016/j.ijsu.2021.106138. [7] Dijkstra ML, Zeebregts CJ, Verhagen HJM, et al. Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data[J]. J Vasc Surg, 2020, 71(3): 780-789. [8] Lal BK, Zhou W, Li ZY, et al. Predictors and outcomes of endoleaks in the Veterans Affairs Open Versus Endovascular Repair(OVER)Trial of abdominal aortic aneurysms[J]. J Vasc Surg, 2015, 62(6): 1394-1404. [9] Seike Y, Matsuda H, Shimizu H, et al. Nationwide analysis of persistent type II endoleak and late outcomes of endovascular abdominal aortic aneurysm repair in Japan: a propensity-matched analysis[J]. Circulation, 2022, 145(14): 1056-1066. [10] Guo Q, Zhao JC, Ma YK, et al. A meta-analysis of translumbar embolization versus transarterial embolization for type II endoleak after endovascular repair of abdominal aortic aneurysm[J]. J Vasc Surg, 2020, 71(3): 1029-1034. [11] Cheadle GA, Dwivedi AJ, Wayne EJ, et al. Transcaval coil embolization of type 2 endoleak after endovascular aortic repair: an institutional review[J]. Vasc Endovascular Surg, 2024, 58(1): 47-53. [12] Knappich C, Kirchhoff F, Fritsche MK, et al. Endovascular aortic repair with sac embolization for the prevention of type II endoleaks(the EVAR-SE study): study protocol for a randomized controlled multicentre study in Germany[J]. Trials, 2024, 25(1): 17. [13] Madigan MC, Singh MJ, Chaer RA, et al. Occult type Ⅰ or Ⅲ endoleaks are a common cause of failure of type Ⅱ endoleak treatment after endovascular aortic repair[J]. J Vasc Surg, 2019, 69(2): 432-439. [14] 姚陈, 孙云昊. 腹主动脉瘤腔内修复术后Ⅱ型内漏的长期临床意义和治疗进展[J]. 临床外科杂志, 2023, 31(12): 1116-1119. YAO Chen, SUN Yunhao. Long term clinical significance and treatment progress of type Ⅱ endoleaks after endovascular treatment of aortic aneurysm[J]. Journal of Clinical Surgery, 2023, 31(12):1116-1119. [15] DOria M, Mastrorilli D, Ziani B. Natural history, diagnosis, and management of type Ⅱ endoleaks after endovascular aortic repair: review and update[J]. Ann Vasc Surg, 2020, 62: 420-431. doi:10.1016/j.avsg.2019.04.048. [16] Kawada H, Goshima S, Sakurai K, et al. Utility of noncontrast magnetic resonance angiography for aneurysm follow-up and detection of endoleaks after endovascular aortic repair[J]. Korean J Radiol, 2021, 22(4): 513-524. [17] Katada Y. Recent update of endovascular type 2 endoleak management[J]. Interv Radiol, 2020, 5(3): 114-119. [18] Karaolanis GI, Antonopoulos CN, Georgakarakos E, et al. Colour duplex and/or contrast-enhanced ultrasound compared with computed tomography angiography for endoleak detection after endovascular abdominal aortic aneurysm repair: a systematic review and meta-analysis[J]. J Clin Med, 2022, 11(13): 3628. [19] Frenzel F, Kubale R, Massmann A, et al. Artifacts in contrast-enhanced ultrasound during follow-up after endovascular aortic repair: Impact on endoleak detection in comparison with computed tomography angiography[J]. Ultrasound Med Biol, 2021, 47(3): 488-498. [20] Voutsinas N, Kim E, Lookstein RA. Predictive factors and strategies to prevent the development of type 2 endoleaks following endovascular aneurysm repair[J]. Semin Intervent Radiol, 2020, 37(4): 389-394. [21] Chen JX, Stavropoulos SW. Type 2 endoleak management[J]. Semin Intervent Radiol, 2020, 37(4): 365-370. [22] van Marrewijk CJ, Fransen G, Laheij RJ, et al. Is a type II endoleak after EVAR a harbinger of risk? Causes and outcome of open conversion and aneurysm rupture during follow-up[J]. Eur J Vasc Endovasc Surg, 2004, 27(2): 128-137. [23] Guo Q, Du XJ, Zhao JC, et al. Prevalence and risk factors of type II endoleaks after endovascular aneurysm repair: a meta-analysis[J]. PLoS One, 2017, 12(2): e0170600. doi:10.1371/journal.pone.0170600. [24] Ide T, Masada K, Kuratani T, et al. Risk analysis of aneurysm sac enlargement caused by type Ⅱ endoleak after endovascular aortic repair[J]. Ann Vasc Surg, 2021, 77: 208-216. doi:10.1016/j.avsg.2021.06.013. [25] Ward TJ, Cohen S, Patel RS, et al. Anatomic risk factors for type-2 endoleak following EVAR: a retrospective review of preoperative CT angiography in 326 patients[J]. Cardiovasc Intervent Radiol, 2014, 37(2): 324-328. [26] 韦金豆, 杨晗, 胡明, 等. 腹主动脉瘤腔内修复术后内漏研究现状[J]. 中华血管外科杂志, 2023, 8(1): 64-68. WEI Jindou, YANG Han, HU Ming, et al. Research status of endoleak after endovascular repair of abdominal aortic aneurysm[J]. Chinese Journal of Vascular Surgery, 2023, 8(1): 64-68. [27] 邱昌涛, 李玥锦, 李柔刚, 等. 腹主动脉瘤腔内修复术后Ⅱ型内漏的预防及治疗研究进展[J]. 医学综述, 2022, 28(13): 2619-2624. QIU Changtao, LI Yuejin, LI Rougang, et al. Progress in prevention and treatment of type Ⅱ endoleaks after endovascular aneurysm repair[J]. Medical Recapitulate, 2022, 28(13): 2619-2624. [28] Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm[J]. J Vasc Surg, 2018, 67(1): 2-77. [29] Wanhainen A, Verzini F, van Herzeele I, et al. Editors choice- European society for vascular surgery(ESVS)2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms[J]. Eur J Vasc Endovasc Surg, 2019, 57(1): 8-93. [30] Ameli-Renani S, Pavlidis V, Morgan RA. Secondary endoleak management following TEVAR and EVAR[J]. Cardiovasc Intervent Radiol, 2020, 43(12): 1839-1854. [31] Heidemann F, Rohlffs F, Tsilimparis N, et al. Transcaval embolization for type Ⅱ endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type Ⅳ thoracoabdominal aortic aneurysm[J]. J Vasc Surg, 2021, 74(1): 38-44. [32] Jouhannet C, Alsac JM, Julia P, et al. Reinterventions for type 2 endoleaks with enlargement of the aneurismal sac after endovascular treatment of abdominal aortic aneurysms[J]. Ann Vasc Surg, 2014, 28(1): 192-200. [33] Shang T, Liu L, Zhou X, et al. Percutaneous contrast-enhanced ultrasound-guided transabdominal sac embolization is an effective technique for treating complicated type II endoleaks after endovascular aneurysm repair[J]. J Vasc Surg, 2022, 75(6): 1918-1925. [34] Stoecker JB, Glaser JD. Review of type III endoleaks[J]. Semin Intervent Radiol, 2020, 37(4): 371-376. [35] Mazzaccaro D, Mazzeo G, Zuccon G, et al. Factors affecting the occurrence of proximal endoleak after endovascular abdominal aortic repair for abdominal aneurysms[J]. J Int Med Res, 2020, 48(11): 300060520971515. doi:10.1177/0300060520971515. [36] Blakeslee-Carter J, Beck A, Spangler E. Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database[J]. BMJ Surg Interv Health Technol, 2020, 2(1): e000054. doi:10.1136/bmjsit-2020-000054. [37] Takahashi B, Kamiya S, Ohta K, et al. Intraoperative findings of an atypical type II endoleak from an artery within the aneurysmal wall after endovascular aneurysm repair[J]. Ann Vasc Dis, 2020, 13(4): 457-460. [38] Schmitz-Rixen T, Böckler D, Vogl TJ, et al. Endovascular and open repair of abdominal aortic aneurysm[J]. Dtsch Arztebl Int, 2020, 117(48): 813-819. [39] Kontopodis N, Galanakis N, Tzartzalou I, et al. An update on the improvement of patient eligibility with the use of new generation endografts for the treatment of abdominal aortic aneurysms[J]. Expert Rev Med Devices, 2020, 17(11): 1231-1238. [40] Yu HYH, Lindström D, Wanhainen A, et al. An updated systematic review and meta-analysis of pre-emptive aortic side branch embolization to prevent type Ⅱ endoleaks after endovascular aneurysm repair[J]. J Vasc Surg, 2023, 77(6): 1815-1821. [41] Niklas N, Malec M, Gutowski P, et al. Effectiveness of inferior mesenteric artery embolization on type Ⅱ endoleak-related complications after endovascular aortic repair(EVAR): systematic review and meta-analysis[J]. J Clin Med, 2022, 11(18): 5491. [42] Yu HYH, Lindström D, Wanhainen A, et al. Systematic review and meta-analysis of prophylactic aortic side branch embolization to prevent type Ⅱ endoleaks[J]. J Vasc Surg, 2020, 72(5): 1783-1792. [43] Samura M, Morikage N, Otsuka R, et al. Endovascular aneurysm repair with inferior mesenteric artery embolization for preventing type Ⅱ endoleak: a prospective randomized controlled trial[J]. Ann Surg, 2020, 271(2): 238-244. |
| [1] | 李彦明 李冬青 陈鹏 张科峰. 聚乙丙交酯膜预防硬膜外瘢痕粘连的实验研究[J]. 山东大学学报(医学版), 2209, 47(6): 33-. |
| [2] | 巩性军,吴树明,张供,李守先,庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-. |
| [3] | 孙红林,管玉强,于培儒,李磊,杜庆霞,丁浩. 支架植入治疗儿童主动脉缩窄并高血压的可行性及近中期疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 58-62. |
| [4] | 林明霞,刘桂斌,马燕花,连曌昱,任洋洋. ATP酶铜转运蛋白α介导的铜死亡途径及在肿瘤治疗中的价值[J]. 山东大学学报 (医学版), 2026, 64(4): 117-124. |
| [5] | 樊呈敏,宋静雨,于书彦,毛雪琴. 舒肝解郁胶囊治疗青少年抑郁障碍的研究进展[J]. 山东大学学报 (医学版), 2026, 64(3): 17-23. |
| [6] | 王皓正,张文雄. Q热伴胸腹主动脉瘤支架植入术后感染1例并文献复习[J]. 山东大学学报 (医学版), 2026, 64(1): 126-130. |
| [7] | 李雪凯,孙淋涵,刘端瑞,倪阳. 乳酸化修饰在肿瘤炎癌进程中的功能与机制研究进展[J]. 山东大学学报 (医学版), 2025, 63(9): 65-76. |
| [8] | 国科,陈绪军,郑宝石,施超,黄克力,曹勇,陈军,吴东凯,张晓慎,罗俊辉,申林,莫绪明,杨岷,王晓武,雷印胜,田茂州,王振东,孟自力,孙忠东,李有金,陆辉辉,孟春营,高峰,陈黔苏,郭能瑞,柳德斌,张楠,林宇,陈文生,宋保国,方智,王海晨,廖晓波,徐朝军. 快通道拔管在全动脉冠脉旁路移植术的多中心临床效果[J]. 山东大学学报 (医学版), 2025, 63(5): 26-32. |
| [9] | 赵芸慕兰,高海燕. 中、高危分化型甲状腺癌患者术后 131I治疗反应及预后的影响因素[J]. 山东大学学报 (医学版), 2025, 63(2): 21-28. |
| [10] | 杨建平,管圣,戈小虎. 利福平浸泡移植物治疗布鲁氏菌感染的主/髂动脉瘤的临床经验[J]. 山东大学学报 (医学版), 2025, 63(12): 17-25. |
| [11] | 韩馨玮,牛月,魏代敏. 激素替代方案准备内膜的冻胚移植前雌激素治疗时间对新生儿体质量的影响[J]. 山东大学学报 (医学版), 2025, 63(11): 46-52. |
| [12] | 黄艳,周应芳,彭超. 青少年子宫内膜异位症的管理要点和策略[J]. 山东大学学报 (医学版), 2025, 63(10): 8-12. |
| [13] | 薛铭,梁静,凌斌. 各种类型子宫内膜异位症疼痛特点及治疗研究进展[J]. 山东大学学报 (医学版), 2025, 63(10): 13-19. |
| [14] | 山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报 (医学版), 2025, 63(1): 10-16. |
| [15] | 宋雅雯,郭联涛,孔德光,孙圣荣. VTCN1导致HR+乳腺癌预后不良及内分泌治疗耐药[J]. 山东大学学报 (医学版), 2025, 63(1): 43-59. |
|
||